PharmExec

Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement

Financially, the agreement includes a $20 million upfront payment to C4 Therapeutics, with the potential for additional ...

C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)

Agreement Focused on Developing DACs With Payloads For Two Oncology Targets, With an Option for a Third TargetC4T to Develop Degraders With ...
Stocktwits on MSN

CCCC stock gets pre-market boost on Roche tie-up to develop cancer treatments

Shares of C4 Therapeutics, Inc. (CCCC) jumped 5% higher in pre-market trading on Thursday, after the company expanded its partnership with Swiss pharmaceutical company Roche to develop cancer ...

C4 Therapeutics deepens Roche alliance to target breakthrough cancer therapies

C4 Therapeutics Inc. CCCC shares rose in Thursday’s session after climbing as high as $3.66 in premarket trading. The company ...
Seeking Alpha

C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen

WATERTOWN, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced it ...